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Endothelin-1 induces apositive inotropic response inisolated left atria of the rat with an IC50 value of 20 nM. The con- 
tractile ffect of endothelin slarger than that of other inotropic hormones such as phenylephrine and epinephrine and 
smaller than that of Bay K8644. In the spontaneously active right atria, endothelin i duces a positive inotropic effect 
with no chronotropic effect. Endothelin does not modify intracellular levels of cAMP under basal conditions or after 
stimulation with isoproterenol but stimulates the formation of inositol phosphates. Mobilization of inositol phospho- 
lipids is observed in the same range of concentrations a  for the contractile action of endothelin. The contractile ac- 
tion of endothelin snot mediated by protein kinase C. It is antagonized by blockers of L-type Ca 2+ channels, low ex- 
ternal Ca 2+ concentrations and drugs uch as caffeine and ryanodine that interfere with Ca 2+ release by the sarcoplasmic 
reticulum. 
Endothelin; Phosphatidylinositol; (Heart) 
1. INTRODUCTION 
Endothelin is a newly discovered 21-residue 
polypeptide that is synthesized by the vascular en- 
dothel ium and displays powerful vasoconstrictive 
[1] and cardiotonic properties [2]. A previous 
paper [3l from this laboratory describes an in- 
vestigation of the action of endothel in on rat 
vascular smooth muscle cells and demonstrates 
that endothel in (i) stimulates the product ion of in- 
ositol phosphates, (ii) mobilizes Ca 2+ from in- 
tracellular stores (see also [4,5l) and (iii) activates 
a non-selective cationic channel that is permeable 
to Ca 2+ with the result that the plasma membrane 
depolarizes and that voltage-dependent L-type 
Ca 2+ channels are activated. It is for that reason 
that the vasoconstricting action of endothel in is 
partially prevented by Ca 2+ channel antagonists 
[3]. 
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The purpose of the present paper is to analyze 
the mechanism of endothelin action on the con- 
tractility of isolated atria of rat heart. 
2. MATERIALS  AND METHODS 
2.1. Materials 
Synthetic endothelin-1 was purchased from Scientific 
Marketing Associates (UK); myo-[2-3H]inositol (19 Ci/mmol) 
from Amersham; (-)-epinephrine, prazosin, caffeine, isopro- 
terenol, phorbol myristate acetate and 1,2-dioctanoyl-rac- 
diacylglycerol (DiC8) from Sigma; Bay K8644 from Bayer; 
ryanodine from Calbiochem and (-)-D888 from Knoll. 
2.2. Contraction measurements 
Atria were isolated from 2-month-old male Sprague-Dawley 
rats and suspended in3 ml organ chambers filled with Tyrode 
solution (127 mM NaC1, 4 mM KC1, 1 mM MgSO4, 1.8 mM 
CaC12, 0.5 mM NaH2PO4, 12 mM NaHCO3, 5 mM glucose) 
maintained at37°C and gassed with 95070 Oz/5070 CO2. Follow- 
ing a 30 min equilibration period with a 1 g load, contractions 
were measured using force displacement transducers coupled to 
a Gould-Brush 2600 polygraph. Left atria were paced at 1 Hz: 
In experiments u ing phenylephrine, atria were pretreated with 
1/~M propranolol to favor the occupancy of ceradrenoceptors 
by phenylephrine. 
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2.3. Preparation of isolated atrial ceils 
Atria were dissected from 1-2-day-old rats and dissociated 
into single cells under sterile conditions at 37°C using 0.1% 
trypsin. Cells were centrifuged and plated into culture dishes at 
a density of 2 x 105 cells/cm 2.The culture medium was Ham's 
F-12 supplemented with 10% fetal bovine serum, 10% horse 
serum, 50 U/ml of penicillin and 200/zg/ml of streptomycin. 
Cultures were maintained at37°C in a humidified atmosphere 
consisting of 95% air/5% CO2. After 2 days, the culture 
medium was changed and cells used 2 days later for biochemical 
experiments. All cultures used showed spontaneous contractile 
activity. 
2.4. Biochemical assays 
Monolayers of rat atrial cells were labelled for 48 h with 
2/zCi/ml of myo-[2)H]inositol and then incubated in an 
Earle's salt solution (140 mM NaCI, 5 mM KCI, 0.8 mM 
MgSO4, 1.8 mM CaClz, 5 mM glucose buffered at pH 7.4 with 
25 mM Hepes-Tris) supplemented with 40 mM LiC1 at 37°C for 
10 rain. Endothelin was then added to the ceils for 10 rain and 
the radioactivity incorporated into inositol phosphates deter- 
mined as described [6]. For cAMP assays, cells were treated 
with 100 nM endothelin in the absence or presence of 10/~M 
isoproterenol for 5 rain and then extracted with an ice-cold 
solution consisting of ethanol/5 mM EDTA (2: 1). The extracts 
were centrifuged and assayed for cAMP content using a 
radioimmunoassay (Amersham). Means :1: SD are indicated. 
3. RESULTS AND DISCUSSION 
Fig.1 compares the contracti le ffects of  endo- 
thelin on isolated left atr ia f rom rat heart with 
those o f  epinephrine, phenylephr ine and the L- 
type Ca 2+ channel act ivator,  Bay K8644. Endo-  
thelin (100 nM) has a biphasic act ion on contrac- 
til ity. Within the first minute of  its appl icat ion,  a
slight negative inotropic effect (< 10% of  initial 
tension) develops. This is fol lowed by a large 
posit ive inotropic  effect that takes 7 -8  rain to 
stabil ize ( f ig . lA) .  Phenylephr ine (acting via 
a radrenoceptors )  also produces a biphasic effect 
on contract ion similar to that o f  endothel in 
( f ig . lC) .  The act ion of  endothel in,  however, is not 
mediated by at -adrenoceptors  since their b lockade 
with prazosin does not prevent his effect (fig. 1A). 
No evidence for an early transient increase in ten- 
sion as described for phenylephr ine act ion on rat 
ventr icular papi l lary muscle [7] was observed with 
either phenylephr ine or endothel in.  The increase in 
tension produced by 100 nM endothel in was 
2.25 + 0.16-fold (n = 32). This is greater than that 
produced by 1/~M epinephrine (1.67 + 0.34-fold, 
n = 5) or 10/zM phenylephr ine (1.90 + 0.33-fold, 
n = 3) and smaller than the effect o f  1/~M Bay 










Fig.1. Kinetics of contractile r sponses to endothelin, phenyl- 
ephrine, epinephrine and Bay K8644 of isolated rat atria. Con- 
centrations: 100nM endothelin (EDT), 1/~M epinephrine 
(EPI), 10 mM phenylephrine (PHE), 1/~M Bay K8644. (A) 
Atria were treated with 1 ,uM prazosin before addition of 
endothelin; (C) atria treated with 1/~M propranol before the 
addition of phenylephrine. (A-D) Left atria paced at 1 Hz, (E) 
right atria showing spontaneous activity. Time scale is 6 min for 
all records. (E) Chart speed was increased uring the experi- 
ment (time scale: 1.30 s) to show that endothelin had no 
chronotropic effect. Arrows indicate time of addition of the 
different effectors. Tension scales: 50 mg (C-E) or 100 mg 
(A,B). W, washes. 
The inotropic effect of  endothel in is stable for at 
least 45 min and decreases lowly upon repetit ive 
washings (fig. 1A). Af ter  recovery of  the initial ten- 
sion, atr ia remain unaffected by a second appl ica- 
t ion of  endothel in.  Endothel in  is inactive at 
< 1 nM. The IC5o value for contracti le act ion was 
determined as 20 nM (fig.2C). This is at least two 
orders of  magnitude higher than the IC5o value for 
the vasoconstr ict ing effect of  the peptide [1]. It 
could be that atr ial  and vascular smooth muscle 
cells express dif ferent types of  receptor for en- 
dothel in.  Endothel in-1 would recognize its binding 
sites with a high aff inity in aort ic smooth muscle 
ceils and with a lower aff inity in atrial cells. 
Endothel in  also produces a biphasic change in 
contract i l i ty in the spontaneously active right atr ia 
( f ig. lE) .  The t ime course of  its act ion is similar to 
144 
Volume 249, number 2 FEBS LETTERS June 1989 
15fA 
_17 











10 9 8 7 
- LOG [ENDOTHELIN (M)] 
Fig.2. Endothelin increases the production of inositol phos- 
phates by rat atrial cells. (A) Intracellular levels of cAMP in 
control (open bars) and endothelin (100 nM) treated atrial cells 
(filled bars). Experiments were performed in the absence or 
presence of 10/~M isoproterenol asindicated. (B) Influence of 
endothelin on intracellular levels of inositol polyphosphates. 
Open bars, controls; filled bars, endothelin (100 nM) treated 
ceils. (C) Dose-response curves for endothelin action on 
contractions of the isolated left atria (o) and on production of 
total inositol phosphates (m). Data are expressed as % of the 
maximum response observed at 100 nM endothelin. For inositol 
phosphates the background level of radioactivity (5000 dpm) 
was subtracted from all data. Maximum counts incorporated 
into total inositol phosphates was 15000 dpm. 
that observed in the left atria. However, the in- 
crease in tension produced by 100 nM endothelin 
(1.53 + 0.08-fold, n = 11) is lower than for the left 
atria. Fig. 1E further shows that endothelin has no 
effect on the beating frequency. In the guinea pig, 
endothelin is less potent han phenylephrine in in- 
creasing the force of contractions of the left atria 
[2] and produces a positive chronotropic effect in 
the right atria [3]. The reason for these differences 
in the action of endothelin between rat and guinea 
pig atria is not known. 
The atrial action of endothelin is different from 
that of fl-adrenergic agonists. It develops lowly as 
compared to that of epinephrine (fig. 1B) and does 
not modify the time course of contractions in both 
guinea pig [2] and rat atria (not shown). En- 
dothelin does not change intracellular levels of 
cAMP both under basal conditions and after 
stimulation of fl-adrenergic receptors with 10/~M 
isoproterenol (fig.2A). These results rule out a 




EDT Bay K 
RYA 




Fig.3. The contractile ffect of endothelin requires external 
Ca 2+ and a functional sarcoplasmic reticulum. Left atria, paced 
at 1 Hz, were treated with different effectors as indicated. 
Concentrations: endothelin (EDT, I00 nM), ( - )-D888 (2/~M), 
EGTA (2 mM), caffeine (CAF, 5 mM), Bay K8644 (1/=M), 
ryanodine (RYA, 1/LM). Tension scales: 25 mg (A), 50 mg 
(C,E) and 100 mg (B,E). Time scale is 6 min for all records. 
possible involvement of cAMP in endothelin 
action. 
Fig.2B shows that endothelin increases intra- 
cellular levels of inositol monophosphate, bisphos- 
phate and trisphosphate in atrial cells. The dose- 
response curve for endothelin action on the pro- 
duction of inositol phosphates (fig.2C) shows an 
IC~0 value of 20 nM and is superimposable onthat 
for contractions. This suggests that hydrolysis of 
phosphatidylinositol s involved in the contractile 
action of endothelin. Phenylephrine, acting via 
tzl-adrenoceptors [7,9,10], and histamine, acting 
via H1 receptors [11], have also been suggested to 
increase myocardial contractility via activation of 
phospholipase C and the production of inositol 
phosphates. 
Endothelin action could involve activation of 
protein kinase C by diacylglycerol which is released 
from phosphatidylinositol in addition to inositol 
phosphates [12]. In order to check this possibility, 
we compared the contractile actions of endothelin, 
phorbol myristate acetate and DiC8. DiC8 (300 
/~M) produces a transient inotropic effect in 
isolated left atria. However, the mean increase in 
tension (1.37___ 0.12-fold, n = 7) is lower than for 
endothelin. We also observed that the action of 
DiC8 does not desensitize the cells nor does it pre- 
vent endothelin action. Similarly, phorbol 
myristate acetate (3/~M) produces only a weak in- 
otropic response (1.15 + 0.07-fold, n = 4) and does 
not desensitize the cells to the action of endothelin. 
These experiments strongly suggest that activation 
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of  protein kinase C cannot account for the con- 
tractile effect of  endothelin. 
Blockade of  Ca 2+ channels with ( - ) -D888 
decreases the amplitude of  contractions o f  the 
isolated left atria and completely prevents en- 
dothelin action (fig.3A). Conversely, a reduction 
in the external free Ca 2+ concentration by addition 
of  EGTA to the bath medium abolishes contrac- 
tions (fig.3B). Addit ion of  endothelin after com- 
plete cessation of  beating does not restore 
contractions (fig.3B). These results suggest that 
Ca 2+ influx via Ca 2÷ channels is probably impor- 
tant for endothelin action. A possible role of  the 
sarcoplasmic reticulum in endothelin action was 
investigated using caffeine and ryanodine. Caf- 
feine produces a transient positive inotropic effect 
in the isolated left atria which is followed by a sus- 
tained negative inotropic effect (fig.3C). After 
treatment with caffeine, atria no longer respond to 
endothelin whereas they still do so to the Ca 2+ 
channel activator Bay K8644 (fig.3C). Ryanodine 
also reduces contractility and prevents the contrac- 
tile effect of  endothelin (fig.3D). It also abolished 
the inotropic action of  endothelin once it had 
developed (fig.3E). Taken together, these results 
suggest hat the sarcoplasmic reticulum is an im- 
portant site for endothelin action. 
In summary, the inotropic effect of  endothelin 
involves both Ca 2÷ entry through L-type Ca 2÷ 
channels and Ca 2÷ release from the sarcoplasmic 
reticulum. Ca 2÷ channels may be important for the 
maintenance of  high Ca 2÷ stores in the sarcoplas- 
mic reticulum [13]. 
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